|
|
|
| Expression of Soluble Advanced Glycosylatio End Product Receptor and its Significance in Patents with Polycystic Ovary Syndrome |
| LIU Li-li |
| The reproductive center , guangdong province Yuebei People′s Hospital, shaoguan 512026 china |
|
|
|
|
Abstract Objective To investigate the expression of solube receptor for advanced glycation end products (sRAGE) in patients with polycystic ovary syndrome (PCOS) and its clinical significance. Methods From January 2015 to April 2016, 80 patients with PCOS were enrolled in the reproductive center of our hospital. PCOS patients were divided into four groups according to whether or not accompanied by hyperandrogenism / insulin resistance (IR). Group A: PCOS+ without NHA + without high insulin resistance (NIR); Group B: PCOS+IR; Group C: PCOS+HA; Group D: PCOS+HA+IR, 20 cases in each group. 20 healthy women were selected as the normal control group (group E). The levels of luteinizing hormone (LH), testosterone (T) and fasting insulin (FINS) were detected by electrochemiluminescence assay, Fasting serum glucose (fasting, blood, glucose, FBG) and ELISA were used to detect serum sRAGE levels by sugar kinase method; the degree of IR was evaluated by HOMA-IR. The correlation between sRAGE and indexes was analyzed. Results sRAGE value from high to the bottom were group E, group A, group C, group B, group D (P<0.05), the difference between the two groups was statistically significant (P<0.05); sRAGE was negatively related to LH, T, FBG, FINS and HOME-IR. Conclusion sRAGE can combine with the ligand of RAGE competitively , weaken the pathological role caused, has potential protective effect in PCOS.
|
|
Received: 19 July 2016
|
|
|
|
|
|
[1] Kelly CJ,Connell JM,cameron IT,et al.The long tem health consequences of polycystic ovary syndrome[J].Br J Obstet GynecoI,2000,107(11):1327-1338.
[2] Zhao Y.Effects of combining low-dose aspirin with a Chinese patent medicine on follicular blood flow and pregnancy outcome [J].Mol Med Rep,2014,10 (5 ) :2372-2376.
[3] The Rotterdam ESHER/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus of diagnostic criteria and long-term health risks related to polycystic ovary syndrome( PCOS) [J].Hum Reprod,2004,19( 1) : 41-47.
[4] Haffner SM, Kennedy E, Gonzalez C ,et al. A prospective analysis of the HOMA model The homeostasis model in the San Antonio Heart Study [J].Diabetes Care,2002 ,25(7):1177-1184.
[5] Xiang S, Hua F, Chen L, et al. Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome[J].Exp Clin Endocrinol Diabetes,2013, 121(2): 115-118.
[6] Enli Y.Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome[J].Gynecol Endocrinol,2013, 29(12): 1036-1039.
[7] Galazis N, Iacovou C, Haoula Z, et al. Metabolomic biomarkers of impaired glucose tolerance and type 2 diabetes mellitus with a potential for risk stratification in women with polycystic ovary syndrome[J].Eur J Obstet Gynecol Reprod Biol,2012, 160(2): 121-130.
[8] Yamagishi S.Role of advanced glycation end products(ACEs) and receptor for AGEs (RAGE) in vascular damage in diabetes[J].Exp Gerontol,201l,46(4):217-224.
[9] Varun PS, Anjana B,Nirmal S, et al.Advanced glycation diabetic complications[J].Korean J Physiol Pharmacol,2014, 18(1):1-14.
[10] Srikanth V, Maczurek A, Phan T, et al. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease[J].Neurobiol Aging,2011,32(5): 763-777.
[11] 涂灵,易迎春.RAGE与C014在多囊卵巢综合征患者中的表达[J].江西医学院学报,2009,49(1):55-58.
[12] 刘丽丽.血清晚期糖基化终产物表达水平与多囊卵巢综合征的相关性[J].中华临床医师杂志(电子版),2016 ,20(10):2989-2992.
[13] He CT, Lee CH, Hsieh C H,et al. Soluble form oi receptor for advanced ulycation end products is associated with obesity and metabolic syndrome in adolescents[J].Int J Endocrinol,2014, 2014:657-607.
[14] 吴艳梅.二甲双胍联合罗格列酮治疗多囊卵巢综合征40例疗效观察[J].医学临床研究,2011,11(28): 2192-2193.
[15] 陆杉,倪运萍,冯妙芙.不同干预措施对青春期肥胖型 PCOS 患者性激素及其临床表现的影响[J].医学临床研究,2015,5(32): 837-839.
|
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2017, 34(5): 993-995. |
|
|
|
|
2017, Vol. 34 
